Literature DB >> 28135849

miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.

Guan Sun1,2, Ying Cao2, Peibei Wang3, Hongmao Song2, Tongwu Bie2, Min Li4.   

Abstract

CONTEXT: Circulating MicroRNAs (miRNAs) are emerging as novel biomarkers for tumour.
OBJECTIVE: Evaluate the diagnostic potential of plasma miR-200b-3p in oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: miR-200b-3p was detected by qRT-PCR in paired pre-operative and post-operative plasmas from 80 OSCC patients and 80 healthy controls.
RESULTS: Plasma miR-200b-3p was significantly upregulated in OSCC, and it was higher in WHO II/III grade than WHO I grade. The AUC of miR-200b-3p for OSCC was 0.9173. miR-200b-3p was significantly downregulated after surgery. High miR-200b-3p expression was associated with poor prognosis. DISCUSSION AND
CONCLUSION: Plasma miR-200b-3p could be a potential diagnostic biomarker for OSCC.

Entities:  

Keywords:  diagnosis; miR-200b-3p; oral squamous cell carcinoma; prognosis

Mesh:

Substances:

Year:  2017        PMID: 28135849     DOI: 10.1080/1354750X.2017.1289241

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  13 in total

1.  Construction and Analysis of a ceRNA Network Reveals Potential Prognostic Markers in Colorectal Cancer.

Authors:  Li Guo; Guowei Yang; Yihao Kang; Sunjing Li; Rui Duan; Lulu Shen; Wenwen Jiang; Bowen Qian; Zibo Yin; Tingming Liang
Journal:  Front Genet       Date:  2020-05-08       Impact factor: 4.599

2.  miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children.

Authors:  Michela Visani; Gianluca Marucci; Dario de Biase; Felice Giangaspero; Francesca Romana Buttarelli; Alba Ariela Brandes; Enrico Franceschi; Giorgia Acquaviva; Alessia Ciarrocchi; Kerry Jane Rhoden; Giovanni Tallini; Annalisa Pession
Journal:  Diagnostics (Basel)       Date:  2020-04-29

Review 3.  Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.

Authors:  Araceli Diez-Fraile; Joke De Ceulaer; Charlotte Derpoorter; Christophe Spaas; Tom De Backer; Philippe Lamoral; Johan Abeloos; Tim Lammens
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

4.  Blood-based circulating microRNAs as potential biomarkers for predicting the prognosis of head and neck cancer-a systematic review.

Authors:  Shankargouda Patil; Saman Warnakulasuriya
Journal:  Clin Oral Investig       Date:  2020-10-03       Impact factor: 3.573

Review 5.  Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications.

Authors:  Ruma Dey Ghosh; Arun Pattatheyil; Susanta Roychoudhury
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

6.  Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Shree Ram Lamichhane; Thanuja Thachil; Harriet Gee; Natalie Milic
Journal:  Dis Markers       Date:  2019-11-18       Impact factor: 3.434

Review 7.  Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.

Authors:  Óscar Rapado-González; Rafael López-López; José Luis López-Cedrún; Gabriel Triana-Martínez; Laura Muinelo-Romay; María Mercedes Suárez-Cunqueiro
Journal:  Cells       Date:  2019-12-17       Impact factor: 6.600

8.  MiR-200b-3p Functions as an Oncogene by Targeting ABCA1 in Lung Adenocarcinoma.

Authors:  Keqiang Liu; Weiqiang Zhang; Jian Tan; Jingbo Ma; Jing Zhao
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

Review 9.  MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.

Authors:  Kumar Rishabh; Soham Khadilkar; Aviral Kumar; Ishu Kalra; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

10.  NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma.

Authors:  Wen-Jie Zhou; Hao-Yu Wang; Jie Zhang; Hai-Ying Dai; Zhi-Xian Yao; Zhong Zheng; Sun Meng-Yan; Ke Wu
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.